Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2026-01-01 @ 9:01 PM
Study NCT ID:
NCT06176235
Status:
WITHDRAWN
Last Update Posted:
2025-08-11
First Post:
2023-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia
Sponsor:
Peking University People's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PKU-TFITP-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None